Signal · Product Feed

Panobinostat 3342 analog 2 Future of combination therapy with

Panobinostat 3342 analog 2 Future of combination therapy with

Name: Panobinostat 3342 analog 2 Future of combination therapy with
Brand: www.drbramiyohan.com
SKU: 72773351166
Price: 80.00 USD
Availability: InStock
Rating: 4.774 (14 reviews)

SKU: 72773351166

4.8

USD80.00 USD110.00

Pay in 4 interest-free payments of $20.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

Live Spec

Panobinostat 3342 analog 2 Future of combination therapy withPanobinostat, also known as NVP LBH 589 or LBH 589, is a cinnamic hydroxamic acid analogue with potential antineoplastic activity. Panobinostat selectively inhibits histone deacetylase (HDAC), inducing hyperacetylation of core histone proteins, which may result in modulation of cell cycle protein expression, cell cycle arrest in the G2 M phase and apoptosis. In addition, this agent appears to modulate the expression of angiogenesis related genes, such

Store: www.drbramiyohan.com · Domain: www.drbramiyohan.com

Description

Future of combination therapy with dabrafenib and trametinib in metastatic melanoma

Molecular Weight: 135

InChi: InChI=1S/C24H28ClN3O

Molecular Weight: 205

Exchange/Return Notes